 Connection
Joshua Yarrow to Testosterone
This is a "connection" page, showing publications Joshua Yarrow has written about Testosterone.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
6.629 |
|
|
|
-
Yarrow JF, Kok HJ, Phillips EG, Conover CF, Lee J, Bassett TE, Buckley KH, Reynolds MC, Wnek RD, Otzel DM, Chen C, Jiron JM, Graham ZA, Cardozo C, Vandenborne K, Bose PK, Aguirre JI, Borst SE, Ye F. Locomotor training with adjuvant testosterone preserves cancellous bone and promotes muscle plasticity in male rats after severe spinal cord injury. J Neurosci Res. 2020 05; 98(5):843-868.
Score: 0.551
-
Otzel DM, Lee J, Ye F, Borst SE, Yarrow JF. Activity-Based Physical Rehabilitation with Adjuvant Testosterone to Promote Neuromuscular Recovery after Spinal Cord Injury. Int J Mol Sci. 2018 Jun 07; 19(6).
Score: 0.497
-
Peterson MD, Belakovskiy A, McGrath R, Yarrow JF. Testosterone Deficiency, Weakness, and Multimorbidity in Men. Sci Rep. 2018 04 12; 8(1):5897.
Score: 0.492
-
Phillips EG, Beggs LA, Ye F, Conover CF, Beck DT, Otzel DM, Ghosh P, Bassit ACF, Borst SE, Yarrow JF. Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury. PLoS One. 2018; 13(3):e0194440.
Score: 0.490
-
Skinner JW, Otzel DM, Bowser A, Nargi D, Agarwal S, Peterson MD, Zou B, Borst SE, Yarrow JF. Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2018 06; 9(3):465-481.
Score: 0.489
-
Yarrow JF, Phillips EG, Conover CF, Bassett TE, Chen C, Teurlings T, Vasconez A, Alerte J, Prock H, Jiron JM, Flores M, Aguirre JI, Borst SE, Ye F. Testosterone Plus Finasteride Prevents Bone Loss without Prostate Growth in a Rodent Spinal Cord Injury Model. J Neurotrauma. 2017 11 01; 34(21):2972-2981.
Score: 0.464
-
Yarrow JF, Wronski TJ, Borst SE. Testosterone and Adult Male Bone: Actions Independent of 5a-Reductase and Aromatase. Exerc Sport Sci Rev. 2015 Oct; 43(4):222-30.
Score: 0.413
-
Borst SE, Yarrow JF. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Am J Physiol Endocrinol Metab. 2015 Jun 15; 308(12):E1035-42.
Score: 0.400
-
Borst SE, Shuster JJ, Zou B, Ye F, Jia H, Wokhlu A, Yarrow JF. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis. BMC Med. 2014 Nov 27; 12:211.
Score: 0.389
-
Yarrow JF, Conover CF, Beggs LA, Beck DT, Otzel DM, Balaez A, Combs SM, Miller JR, Ye F, Aguirre JI, Neuville KG, Williams AA, Conrad BP, Gregory CM, Wronski TJ, Bose PK, Borst SE. Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injury. J Neurotrauma. 2014 May 01; 31(9):834-45.
Score: 0.374
-
Yarrow JF, Beggs LA, Conover CF, McCoy SC, Beck DT, Borst SE. Influence of androgens on circulating adiponectin in male and female rodents. PLoS One. 2012; 7(10):e47315.
Score: 0.336
-
Yarrow JF, Conover CF, Lipinska JA, Santillana CA, Wronski TJ, Borst SE. Methods to quantify sex steroid hormones in bone: applications to the study of androgen ablation and administration. Am J Physiol Endocrinol Metab. 2010 Nov; 299(5):E841-7.
Score: 0.290
-
Yarrow JF, Conover CF, Purandare AV, Bhakta AM, Zheng N, Conrad B, Altman MK, Franz SE, Wronski TJ, Borst SE. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats. Am J Physiol Endocrinol Metab. 2008 Nov; 295(5):E1213-22.
Score: 0.253
-
Yarrow JF, Borsa PA, Borst SE, Sitren HS, Stevens BR, White LJ. Early-phase neuroendocrine responses and strength adaptations following eccentric-enhanced resistance training. J Strength Cond Res. 2008 Jul; 22(4):1205-14.
Score: 0.250
-
Conover CF, Yarrow JF, Garrett TJ, Ye F, Quinlivan EP, Cannady DF, Peterson MD, Borst SE. High Prevalence of Low Serum Biologically Active Testosterone in?Older Male Veterans. J Am Med Dir Assoc. 2017 Apr 01; 18(4):366.e17-366.e24.
Score: 0.114
-
Beggs LA, Ye F, Ghosh P, Beck DT, Conover CF, Balaez A, Miller JR, Phillips EG, Zheng N, Williams AA, Aguirre JI, Wronski TJ, Bose PK, Borst SE, Yarrow JF. Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss. J Bone Miner Res. 2015 Apr; 30(4):681-9.
Score: 0.100
-
Beck DT, Yarrow JF, Beggs LA, Otzel DM, Ye F, Conover CF, Miller JR, Balaez A, Combs SM, Leeper AM, Williams AA, Lachacz SA, Zheng N, Wronski TJ, Borst SE. Influence of aromatase inhibition on the bone-protective effects of testosterone. J Bone Miner Res. 2014 Nov; 29(11):2405-13.
Score: 0.097
-
Borst SE, Yarrow JF, Fernandez C, Conover CF, Ye F, Meuleman JR, Morrow M, Zou B, Shuster JJ. Cognitive effects of testosterone and finasteride administration in older hypogonadal men. Clin Interv Aging. 2014; 9:1327-33.
Score: 0.095
-
Beggs LA, Yarrow JF, Conover CF, Meuleman JR, Beck DT, Morrow M, Zou B, Shuster JJ, Borst SE. Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone. Am J Physiol Endocrinol Metab. 2014 Sep 01; 307(5):E456-61.
Score: 0.095
-
Ye F, McCoy SC, Ross HH, Bernardo JA, Beharry AW, Senf SM, Judge AR, Beck DT, Conover CF, Cannady DF, Smith BK, Yarrow JF, Borst SE. Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle. Steroids. 2014 Sep; 87:59-66.
Score: 0.094
-
Borst SE, Yarrow JF, Conover CF, Nseyo U, Meuleman JR, Lipinska JA, Braith RW, Beck DT, Martin JS, Morrow M, Roessner S, Beggs LA, McCoy SC, Cannady DF, Shuster JJ. Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial. Am J Physiol Endocrinol Metab. 2014 Feb 15; 306(4):E433-42.
Score: 0.091
-
Yarrow JF, Beck DT, Conover CF, Beggs LA, Goldberger BA, Borst SE. Invalidation of a commercially available human 5a-dihydrotestosterone immunoassay. Steroids. 2013 Dec 11; 78(12-13):1220-5.
Score: 0.089
-
Yarrow JF, Conover CF, McCoy SC, Lipinska JA, Santillana CA, Hance JM, Cannady DF, VanPelt TD, Sanchez J, Conrad BP, Pingel JE, Wronski TJ, Borst SE. 17?-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate. Am J Physiol Endocrinol Metab. 2011 Apr; 300(4):E650-60.
Score: 0.075
-
Yarrow JF, Borsa PA, Borst SE, Sitren HS, Stevens BR, White LJ. Neuroendocrine responses to an acute bout of eccentric-enhanced resistance exercise. Med Sci Sports Exerc. 2007 Jun; 39(6):941-7.
Score: 0.058
-
Mumford PW, Romero MA, Mao X, Mobley CB, Kephart WC, Haun CT, Roberson PA, Young KC, Martin JS, Yarrow JF, Beck DT, Roberts MD. Cross talk between androgen and Wnt signaling potentially contributes to age-related skeletal muscle atrophy in rats. J Appl Physiol (1985). 2018 08 01; 125(2):486-494.
Score: 0.031
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|